PTJ
LEGN icon

Paul Tudor Jones’s Legend Biotech LEGN Stock Holding History

Paul Tudor Jones’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,700
Closed -$302K – 3961
2026
Q1 		$302K Sell
16,700
-1,400
-8% -$26.7K ﹤0.01% 3130
2025
Q4 		$393K Buy
+18,100
New +$518K ﹤0.01% 2857
2025
Q2 		– Sell
-7,900
Closed -$268K – 3532
2025
Q1 		$268K Sell
7,900
-400
-5% -$14.3K ﹤0.01% 2673
2024
Q4 		$270K Buy
+8,300
New +$344K ﹤0.01% 2653

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Paul Tudor Jones's LEGN Position: Q2 2026 in Review

Paul Tudor Jones reduced its Legend Biotech (LEGN) stake by 47% in Q2 2026, selling an estimated $702K and leaving 29,066 shares worth $839K. The position accounts for ﹤0.01% of the portfolio, ranked #2537.

Paul Tudor Jones first reported a position in LEGN in Q2 2020 and has held it in 8 quarters since. The position peaked at $2.44M in Q1 2025. 217 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Paul Tudor Jones held 29,066 shares of Legend Biotech worth $839K as of Q2 2026.
  • Paul Tudor Jones sold 26,036 Legend Biotech shares in Q2 2026, an estimated $702K.
  • Legend Biotech made up ﹤0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #2537 holding.
  • Paul Tudor Jones first reported a position in Legend Biotech in Q2 2020 and has held it in 8 quarters since.
  • Paul Tudor Jones's Legend Biotech position peaked at $2.44M in Q1 2025.
  • 217 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.